Table I.

Patient and tumor characteristics

	Neoadjuvant Chemotherapy n=93	Surgery first n=218	p-value
Age			p<0.01
Range	35 – 86	29 – 91
Median	54	60
Clinical T Stage			p<0.01
T1	11 (11.8%)	130 (59.6%)
T2	48 (51.6%)	70 (32.1%)
T3	25 (26.9%)	17 (7.8%)
T4	9 (9.7%)	1 (0.5%)
Clinical N Status			p<0.01
N0	42 (45.2%)	197 (90.3%)
N1	40 (43.0%)	20 (9.2%)
N2	2 (2.1%)	0 (0.0%)
N3	9 (9.7%)	1 (0.5%)
ER/PR Status			p=0.26
ER positive/PR positive	57 (62.0%)	142 (66.7%)
ER positive/PR negative	27 (29.4%)	63 (29.6%)
ER negative/PR positive	2 (2.2%)	1 (0.5%)
ER negative/PR negative	6 (6.5%)	7 (3.3%)
First Surgical Procedure			p<0.01
BCT	28 (30.1%)	107 (49.1%)
Mastectomy	65 (69.9%)	111 (50.9%)
Final Surgical Procedure			P<0.01
BCT	16 (17.2%)	92 (42.2%)
Mastectomy	77 (82.8%)	126 (57.8%)
Median Follow Up			p<0.01
Years	4	2.8